Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference newsletter


  Free Subscription


1 Antimicrob Agents Chemother
1 Antiviral Res
2 BMC Pediatr
13 BMJ
2 Cell
2 Drugs
9 Epidemiol Infect
1 Eur J Epidemiol
1 J Epidemiol Community Health
3 J Exp Med
1 J Gen Virol
9 J Infect
7 J Infect Dis
3 J Virol
5 Lancet
5 Lancet Child Adolesc Health
2 Lancet Diabetes Endocrinol
3 Lancet Gastroenterol Hepatol
11 Lancet Glob Health
4 Lancet Haematol
13 Lancet Infect Dis
2 Lancet Neurol
4 Lancet Psychiatry
2 Lancet Public Health
1 Lancet Respir Med
10 MMWR Morb Mortal Wkly Rep
7 N Engl J Med
1 Pediatrics
1 PLoS Biol
3 PLoS Med
33 PLoS One
3 Proc Natl Acad Sci U S A
11 Vaccine
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. FINTELMAN-RODRIGUES N, Sacramento CQ, Ribeiro Lima C, Souza da Silva F, et al
    Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production.
    Antimicrob Agents Chemother. 2020 Aug 5. pii: AAC.00825.
    PubMed         Abstract available

    Antiviral Res

  2. SAITO R, Osada H, Wagatsuma K, Chon I, et al
    Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018-2019 season and detection of variant influenza a viruses with polymerase acidic subunit substitutions.
    Antiviral Res. 2020;183:104951.
    PubMed         Abstract available

    BMC Pediatr

  3. GHIMIRE LV, Chou FS, Moon-Grady AJ
    Impact of congenital heart disease on outcomes among pediatric patients hospitalized for influenza infection.
    BMC Pediatr. 2020;20:450.
    PubMed         Abstract available

  4. FREIJ BJ, Gebara BM, Tariq R, Wang AM, et al
    Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child.
    BMC Pediatr. 2020;20:429.
    PubMed         Abstract available


  5. ALWAN NA, Attree E, Blair JM, Bogaert D, et al
    From doctors as patients: a manifesto for tackling persisting symptoms of covid-19.
    BMJ. 2020;370:m3565.

  6. ESTCOURT LJ, Roberts DJ
    Convalescent plasma for covid-19.
    BMJ. 2020;370:m3516.

  7. Update to living systematic review on drug treatments for covid-19.
    BMJ. 2020;370:m3536.

  8. GREEN ST, Cladi L
    Covid-19: the humanities and social sciences have much to contribute to beating this pandemic and the next.
    BMJ. 2020;370:m3523.

  9. BURGESS S, Gill D
    Rising numbers of positive covid-19 tests in the UK.
    BMJ. 2020;370:m3605.

  10. URCH CE, George AJT
    Let's stop talking about covid-safe and covid-secure-it's covid-mitigated.
    BMJ. 2020;370:m3616.

  11. GOH S
    Covid-19: What's in a name? Isolating the term "quarantine" from other contamination.
    BMJ. 2020;370:m3674.

  12. AGIUS RM, Robertson JFR, Kendrick D, Sewell HF, et al
    Covid-19 in the workplace.
    BMJ. 2020;370:m3577.

  13. LYON JO
    Flu vaccination programme: could medical students be the answer?
    BMJ. 2020;370:m3698.

  14. MACDONALD E, Middleton J, Lalloo D, Greenhalgh T, et al
    Safely returning clinically vulnerable people to work.
    BMJ. 2020;370:m3600.

    Covid-19: "protecting the NHS" encourages people with symptoms to stay at home.
    BMJ. 2020;370:m3515.

  16. SWANN OV, Holden KA, Turtle L, Pollock L, et al
    Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
    BMJ. 2020;370:m3249.
    PubMed         Abstract available

  17. DEEKS JJ, Brookes AJ, Pollock AM
    Operation Moonshot proposals are scientifically unsound.
    BMJ. 2020;370:m3699.


  18. COLUBRI A, Kemball M, Sani K, Boehm C, et al
    Preventing Outbreaks through Interactive, Experiential Real-Life Simulations.
    Cell. 2020;182:1366-1371.
    PubMed         Abstract available

  19. SCHULTE-SCHREPPING J, Reusch N, Paclik D, Bassler K, et al
    Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
    Cell. 2020;182:1419-1440.
    PubMed         Abstract available


  20. VRACHATIS DA, Giotaki SG, Giannopoulos G, Deftereos S, et al
    Comment on: "Pharmaco-Immunomodulatory Therapy in COVID-19".
    Drugs. 2020;80:1499-1500.

  21. RIZK JG, Kalantar-Zadeh K, Mehra MR, Lavie CJ, et al
    Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19".
    Drugs. 2020;80:1501-1503.

    Epidemiol Infect

  22. TINTO B, Salinas S, Dicko A, Kagone TS, et al
    Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.
    Epidemiol Infect. 2020;148:e213.
    PubMed         Abstract available

  23. HAW NJL, Uy J, Sy KTL, Abrigo MRM, et al
    Epidemiological profile and transmission dynamics of COVID-19 in the Philippines.
    Epidemiol Infect. 2020;148:e204.
    PubMed         Abstract available

  24. LAI R, Chen E, Gao W, Cheng C, et al
    Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China.
    Epidemiol Infect. 2020;148:e205.
    PubMed         Abstract available

  25. GAYAWAN E, Awe OO, Oseni BM, Uzochukwu IC, et al
    The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa.
    Epidemiol Infect. 2020;148:e212.
    PubMed         Abstract available

  26. HAIDER N, Yavlinsky A, Chang YM, Hasan MN, et al
    The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
    Epidemiol Infect. 2020;148:e210.
    PubMed         Abstract available

  27. WANG X, Li X, Shang Y, Wang J, et al
    Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Epidemiol Infect. 2020;148:e211.
    PubMed         Abstract available

  28. DUAN P, Deng ZQ, Pan ZY, Wang YP, et al
    Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
    Epidemiol Infect. 2020;148:e214.
    PubMed         Abstract available

  29. BISWAS RK, Afiaz A, Huq S
    Underreporting COVID-19: the curious case of the Indian subcontinent.
    Epidemiol Infect. 2020;148:e207.
    PubMed         Abstract available

  30. ELIMIAN KO, Ochu CL, Ilori E, Oladejo J, et al
    Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
    Epidemiol Infect. 2020;148:e208.
    PubMed         Abstract available

    Eur J Epidemiol

    Good science is good science: we need specialists, not sects.
    Eur J Epidemiol. 2020;35:519-522.

    J Epidemiol Community Health

  32. HIAM L, Dorling D, McKee M
    Austerity, not influenza, caused the UK's health to deteriorate. Let's not make the same mistake again.
    J Epidemiol Community Health. 2020 Oct 1. pii: jech-2020-215556.

    J Exp Med

  33. VERAS FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, et al
    SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
    J Exp Med. 2020;217.
    PubMed         Abstract available

  34. PAIK DH, Farber DL
    Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity.
    J Exp Med. 2021;218.
    PubMed         Abstract available

  35. RADERMECKER C, Detrembleur N, Guiot J, Cavalier E, et al
    Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.
    J Exp Med. 2020;217.
    PubMed         Abstract available

    J Gen Virol

  36. MOOIJ P, Mortier D, Stammes M, Fagrouch Z, et al
    Aerosolized pH1N1 influenza infection induces less systemic and local immune activation in the lung than combined intrabronchial, nasal and oral exposure in cynomolgus macaques.
    J Gen Virol. 2020 Sep 25. doi: 10.1099/jgv.0.001489.
    PubMed         Abstract available

    J Infect

  37. PRAZUCK T, Giache S, Gubavu C, Colin M, et al
    Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30448.

  38. LIN Z, Long F, Yang Y, Chen X, et al
    Serum ferritin as an independent risk factor for severity in COVID-19 patients.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30434.

  39. BOUZA E, Perez-Granda MJ, Escribano P, Fernandez-Del Rey R, et al
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30437.

  40. CANTINI F, Niccoli L, Nannini C, Matarrese D, et al
    Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30433.

  41. DAUNT A, Perez-Guzman PN, Liew F, Hauck K, et al
    Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30430.

  42. TANG JW, Young S, May S, Bird P, et al
    Comparing hospitalised, community and staff COVID-19 infection rates during the early phase of the evolving COVID-19 epidemic.
    J Infect. 2020 May 19. pii: S0163-4453(20)30308.

  43. CAI C, Ahmed OA, Shen H, Zeng S, et al
    Which cancer type has the highest risk of COVID-19 infection?
    J Infect. 2020 May 19. pii: S0163-4453(20)30307.

  44. SHI L, Wang Y, Wang Y, Duan G, et al
    Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.
    J Infect. 2020 May 14. pii: S0163-4453(20)30288.

    Clinical and conceptual comments on "Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis".
    J Infect. 2020 May 11. pii: S0163-4453(20)30287.

    J Infect Dis

  46. LAM KW, Chow KW, Vo J, Hou W, et al
    Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
    J Infect Dis. 2020;222:1256-1264.
    PubMed         Abstract available

  47. RIJKERS G, Murk JL, Wintermans B, van Looy B, et al
    Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    J Infect Dis. 2020;222:1265-1269.
    PubMed         Abstract available

  48. MEISTER TL, Bruggemann Y, Todt D, Conzelmann C, et al
    Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1289-1292.
    PubMed         Abstract available

  49. LEUZINGER K, Roloff T, Gosert R, Sogaard K, et al
    Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
    J Infect Dis. 2020;222:1270-1279.
    PubMed         Abstract available

  50. BOND K, Nicholson S, Lim SM, Karapanagiotidis T, et al
    Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting.
    J Infect Dis. 2020;222:1280-1288.
    PubMed         Abstract available

  51. LIU X, Tang J, Xie R, Li W, et al
    Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study.
    J Infect Dis. 2020;222:1293-1297.
    PubMed         Abstract available

  52. LI JZ, Yu XG
    Overcoming Challenges in Coronavirus Disease 19 Translational Research.
    J Infect Dis. 2020;222:1254-1255.

    J Virol

  53. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    PubMed         Abstract available

  54. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    PubMed         Abstract available

  55. NELSON MI, Perofsky A, McBride DS, Rambo-Martin BL, et al
    A heterogenous swine show circuit drives zoonotic transmission of influenza A viruses in the United States.
    J Virol. 2020 Sep 30. pii: JVI.01453-20. doi: 10.1128/JVI.01453.
    PubMed         Abstract available


  56. SALONER B, Parish K, Ward JA, DiLaura G, et al
    COVID-19 Cases and Deaths in Federal and State Prisons.
    JAMA. 2020 Jul 8. pii: 2768249. doi: 10.1001/jama.2020.12528.

  57. CARFI A, Bernabei R, Landi F
    Persistent Symptoms in Patients After Acute COVID-19.
    JAMA. 2020 Jul 9. pii: 2768351. doi: 10.1001/jama.2020.12603.

    Challenges Estimating Total Lives Lost in COVID-19 Decisions: Consideration of Mortality Related to Unemployment, Social Isolation, and Depression.
    JAMA. 2020 Jul 8. pii: 2768250. doi: 10.1001/jama.2020.12187.

  59. RUBIN R
    School Superintendents Confront COVID-19-"There Are No Good Options for Next Year".
    JAMA. 2020 Jul 9. pii: 2768352. doi: 10.1001/jama.2020.12575.

  60. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
    Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
    PubMed         Abstract available

  61. WIERSINGA WJ, Prescott HC
    What Is COVID-19?
    JAMA. 2020 Jul 10. pii: 2768390. doi: 10.1001/jama.2020.12984.

  62. BILALOGLU S, Aphinyanaphongs Y, Jones S, Iturrate E, et al
    Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.
    JAMA. 2020 Jul 20. pii: 2768715. doi: 10.1001/jama.2020.13372.

  63. KAMRATH C, Monkemoller K, Biester T, Rohrer TR, et al
    Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany.
    JAMA. 2020 Jul 20. pii: 2768716. doi: 10.1001/jama.2020.13445.

  64. PETKOVA E, Antman EM, Troxel AB
    Pooling Data From Individual Clinical Trials in the COVID-19 Era.
    JAMA. 2020 Jul 22. pii: 2768851. doi: 10.1001/jama.2020.13042.

  65. WALKER D
    The Work of Philanthropy in Responding to COVID-19 and Addressing Inequality: A New Foundation.
    JAMA. 2020 Jul 23. pii: 2768893. doi: 10.1001/jama.2020.12904.

  66. KHOURY P, Azar E, Hitti E
    COVID-19 Response in Lebanon: Current Experience and Challenges in a Low-Resource Setting.
    JAMA. 2020 Jul 23. pii: 2768892. doi: 10.1001/jama.2020.12695.

  67. O'CALLAGHAN KP, Blatz AM, Offit PA
    Developing a SARS-CoV-2 Vaccine at Warp Speed.
    JAMA. 2020 Jul 6. pii: 2768155. doi: 10.1001/jama.2020.12190.

  68. ZYLKE JW, Bauchner H
    Mortality and Morbidity: The Measure of a Pandemic.
    JAMA. 2020;324:458-459.

  69. MALANI AN, Sherbeck JP, Malani PN
    Convalescent Plasma and COVID-19.
    JAMA. 2020 Jun 12. pii: 2767351. doi: 10.1001/jama.2020.10699.

  70. EMERUWA UN, Ona S, Shaman JL, Turitz A, et al
    Associations Between Built Environment, Neighborhood Socioeconomic Status, and SARS-CoV-2 Infection Among Pregnant Women in New York City.
    JAMA. 2020 Jun 18. pii: 2767631. doi: 10.1001/jama.2020.11370.

  71. MARTINEZ DA, Hinson JS, Klein EY, Irvin NA, et al
    SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region.
    JAMA. 2020 Jun 18. pii: 2767632. doi: 10.1001/jama.2020.11374.

  72. WHITE DB, Angus DC
    A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
    JAMA. 2020 Jun 24. pii: 2767751. doi: 10.1001/jama.2020.11464.

  73. BARNETT ML, Hu L, Martin T, Grabowski DC, et al
    Mortality, Admissions, and Patient Census at SNFs in 3 US Cities During the COVID-19 Pandemic.
    JAMA. 2020 Jun 24. pii: 2767750. doi: 10.1001/jama.2020.11642.

  74. AUSTIN JM, Kachalia A
    The State of Health Care Quality Measurement in the Era of COVID-19: The Importance of Doing Better.
    JAMA. 2020 Jun 25. pii: 2767747. doi: 10.1001/jama.2020.11461.

    Rereading Arrowsmith in the COVID-19 Pandemic.
    JAMA. 2020 Jun 26. pii: 2767891. doi: 10.1001/jama.2020.11489.

  76. ABBASI J
    Taking a Closer Look at COVID-19, Health Inequities, and Racism.
    JAMA. 2020 Jun 29. pii: 2767948. doi: 10.1001/jama.2020.11672.

  77. HALPERN SD, Truog RD, Miller FG
    Cognitive Bias and Public Health Policy During the COVID-19 Pandemic.
    JAMA. 2020 Jun 29. pii: 2767950. doi: 10.1001/jama.2020.11623.

    A Cruel COVID-19 Irony.
    JAMA. 2020 Jun 30. pii: 2767995. doi: 10.1001/jama.2020.11882.

  79. WOOLF SH, Chapman DA, Sabo RT, Weinberger DM, et al
    Excess Deaths From COVID-19 and Other Causes, March-April 2020.
    JAMA. 2020 Jul 1. pii: 2768086. doi: 10.1001/jama.2020.11787.

    Women Physicians and the COVID-19 Pandemic.
    JAMA. 2020 Jul 31. pii: 2769140. doi: 10.1001/jama.2020.14797.

  81. BACHIREDDY C, Chen C, Dar M
    Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid's Response to COVID-19.
    JAMA. 2020 Mar 19. pii: 2763487. doi: 10.1001/jama.2020.4272.

  82. CUTLER DM, Nikpay S, Huckman RS
    The Business of Medicine in the Era of COVID-19.
    JAMA. 2020 May 1. pii: 2765668. doi: 10.1001/jama.2020.7242.

  83. BAUCHNER H, Fontanarosa PB
    Randomized Clinical Trials and COVID-19: Managing Expectations.
    JAMA. 2020 May 4. pii: 2765696. doi: 10.1001/jama.2020.8115.

  84. THOMAS LE, Li F, Pencina MJ
    Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial.
    JAMA. 2020;323:2417-2418.

  85. PERSAD G, Emanuel EJ
    The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.

  86. HALL MA, Studdert DM
    Privileges and Immunity Certification During the COVID-19 Pandemic.
    JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.

  87. SETHURAMAN N, Jeremiah SS, Ryo A
    Interpreting Diagnostic Tests for SARS-CoV-2.
    JAMA. 2020 May 6. pii: 2765837. doi: 10.1001/jama.2020.8259.

  88. BOLLYKY TJ, Gostin LO, Hamburg MA
    The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
    JAMA. 2020 May 7. pii: 2765944. doi: 10.1001/jama.2020.6641.

  89. RANDHAWA AK, Fisher LH, Greninger AL, Li SS, et al
    Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020.
    JAMA. 2020 May 8. pii: 2766035. doi: 10.1001/jama.2020.8097.

  90. KIRKCALDY RD, King BA, Brooks JT
    COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
    JAMA. 2020 May 11. pii: 2766097. doi: 10.1001/jama.2020.7869.

  91. PERENCEVICH EN, Diekema DJ, Edmond MB
    Moving Personal Protective Equipment Into the Community: Face Shields and Containment of COVID-19.
    JAMA. 2020 Apr 29. pii: 2765525. doi: 10.1001/jama.2020.7477.

  92. MARINI JJ, Gattinoni L
    Management of COVID-19 Respiratory Distress.
    JAMA. 2020 Apr 24. pii: 2765302. doi: 10.1001/jama.2020.6825.

  93. SPINATO G, Fabbris C, Polesel J, Cazzador D, et al
    Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.
    JAMA. 2020 Apr 22. pii: 2765183. doi: 10.1001/jama.2020.6771.

  94. MERCHANT RM, Lurie N
    Social Media and Emergency Preparedness in Response to Novel Coronavirus.
    JAMA. 2020;323:2011-2012.

  95. GRABOWSKI DC, Joynt Maddox KE
    Postacute Care Preparedness for COVID-19: Thinking Ahead.
    JAMA. 2020 Mar 25. pii: 2763818. doi: 10.1001/jama.2020.4686.

  96. SCHRAG D, Hershman DL, Basch E
    Oncology Practice During the COVID-19 Pandemic.
    JAMA. 2020;323:2005-2006.

  97. KIM D, Quinn J, Pinsky B, Shah NH, et al
    Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.
    JAMA. 2020 Apr 15. pii: 2764787. doi: 10.1001/jama.2020.6266.

  98. RUBIN R
    Finding Ways to Reduce Coronavirus Exposure During Dialysis.
    JAMA. 2020;323:1993-1995.

  99. DESAI AN, Aronoff DM
    Masks and Coronavirus Disease 2019 (COVID-19).
    JAMA. 2020 Apr 17. pii: 2764955. doi: 10.1001/jama.2020.6437.

  100. CHOW EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, et al
    Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington.
    JAMA. 2020 Apr 17. pii: 2764953. doi: 10.1001/jama.2020.6637.

  101. BAUCHNER H, Easley TJ
    Health Care Heroes of the COVID-19 Pandemic.
    JAMA. 2020;323:2021.

  102. RICHARDSON S, Hirsch JS, Narasimhan M, Crawford JM, et al
    Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
    JAMA. 2020 Apr 22. pii: 2765184. doi: 10.1001/jama.2020.6775.
    PubMed         Abstract available

  103. WEBB HOOPER M, Napoles AM, Perez-Stable EJ
    COVID-19 and Racial/Ethnic Disparities.
    JAMA. 2020 May 11. pii: 2766098. doi: 10.1001/jama.2020.8598.

  104. ROSENBERG ES, Dufort EM, Udo T, Wilberschied LA, et al
    Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
    JAMA. 2020 May 11. pii: 2766117. doi: 10.1001/jama.2020.8630.
    PubMed         Abstract available

  105. ARORA KS, Mauch JT, Gibson KS
    Labor and Delivery Visitor Policies During the COVID-19 Pandemic: Balancing Risks and Benefits.
    JAMA. 2020 May 22. pii: 2766598. doi: 10.1001/jama.2020.7563.

  106. CAMPBELL KH, Tornatore JM, Lawrence KE, Illuzzi JL, et al
    Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut.
    JAMA. 2020 May 26. pii: 2766650. doi: 10.1001/jama.2020.8904.

  107. TROGEN B, Oshinsky D, Caplan A
    Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    JAMA. 2020 May 26. pii: 2766651. doi: 10.1001/jama.2020.8917.

  108. SEN S, Karaca-Mandic P, Georgiou A
    Association of Stay-at-Home Orders With COVID-19 Hospitalizations in 4 States.
    JAMA. 2020 May 27. pii: 2766673. doi: 10.1001/jama.2020.9176.

  109. USCHER-PINES L, Huskamp HA, Mehrotra A
    Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model.
    JAMA. 2020;324:39-40.

  110. VADUGANATHAN M, van Meijgaard J, Mehra MR, Joseph J, et al
    Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.
    JAMA. 2020 May 28. pii: 2766773. doi: 10.1001/jama.2020.9184.

  111. LI L, Zhang W, Hu Y, Tong X, et al
    Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Jun 3. pii: 2766943. doi: 10.1001/jama.2020.10044.
    PubMed         Abstract available

  112. GLIED S, Levy H
    The Potential Effects of Coronavirus on National Health Expenditures.
    JAMA. 2020;323:2001-2002.

  113. DEGESYS NF, Wang RC, Kwan E, Fahimi J, et al
    Correlation Between N95 Extended Use and Reuse and Fit Failure in an Emergency Department.
    JAMA. 2020;324:94-96.

  114. DEL RIO C, Malani P
    Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
    JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.

  115. ANTIEL RM
    Oedipus and the Coronavirus Pandemic.
    JAMA. 2020;323:2231-2232.

  116. SCHALLER T, Hirschbuhl K, Burkhardt K, Braun G, et al
    Postmortem Examination of Patients With COVID-19.
    JAMA. 2020 May 21. pii: 2766557. doi: 10.1001/jama.2020.8907.

  117. HAMIEL U, Kozer E, Youngster I
    SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.
    JAMA. 2020 May 13. pii: 2766182. doi: 10.1001/jama.2020.8189.

  118. RUBIN R
    Global Effort to Collect Data on Ventilated Patients With COVID-19.
    JAMA. 2020 May 13. pii: 2766183. doi: 10.1001/jama.2020.8341.

  119. ELHARRAR X, Trigui Y, Dols AM, Touchon F, et al
    Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure.
    JAMA. 2020 May 15. pii: 2766292. doi: 10.1001/jama.2020.8255.

  120. ANGULO FJ, Finelli L, Swerdlow DL
    Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level.
    JAMA. 2020 May 15. pii: 2766293. doi: 10.1001/jama.2020.7872.

  121. SARTINI C, Tresoldi M, Scarpellini P, Tettamanti A, et al
    Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit.
    JAMA. 2020 May 15. pii: 2766291. doi: 10.1001/jama.2020.7861.

  122. COLLINS FS, Stoffels P
    Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times.
    JAMA. 2020 May 18. pii: 2766371. doi: 10.1001/jama.2020.8920.

  123. SCHAFFER DEROO S, Pudalov NJ, Fu LY
    Planning for a COVID-19 Vaccination Program.
    JAMA. 2020 May 18. pii: 2766370. doi: 10.1001/jama.2020.8711.

  124. ABBASI J
    Prioritizing Physician Mental Health as COVID-19 Marches On.
    JAMA. 2020 May 20. pii: 2766525. doi: 10.1001/jama.2020.5205.

  125. WHITCROFT KL, Hummel T
    Olfactory Dysfunction in COVID-19: Diagnosis and Management.
    JAMA. 2020 May 20. pii: 2766523. doi: 10.1001/jama.2020.8391.

  126. MCGINTY EE, Presskreischer R, Han H, Barry CL, et al
    Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020.
    JAMA. 2020;324:93-94.

  127. AUGER KA, Shah SS, Richardson T, Hartley D, et al
    Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US.
    JAMA. 2020 Jul 29. pii: 2769034. doi: 10.1001/jama.2020.14348.
    PubMed         Abstract available

  128. DIBNER KA, Schweingruber HA, Christakis DA
    Reopening K-12 Schools During the COVID-19 Pandemic: A Report From the National Academies of Sciences, Engineering, and Medicine.
    JAMA. 2020 Jul 29. pii: 2769036. doi: 10.1001/jama.2020.14745.

  129. BONOW RO, O'Gara PT, Yancy CW
    Cardiology and COVID-19.
    JAMA. 2020;324:1131-1132.

  130. REDBERG RF, Katz M, Steinbrook R
    Internal Medicine and COVID-19.
    JAMA. 2020;324:1135-1136.

  131. KIBBE MR
    Surgery and COVID-19.
    JAMA. 2020;324:1151-1152.

  132. RIVARA FP, Fihn SD, Perencevich EN
    JAMA Network Open and COVID-19.
    JAMA. 2020;324:1153-1154.

  133. SHINKAI K, Bruckner AL
    Dermatology and COVID-19.
    JAMA. 2020;324:1133-1134.

    Otolaryngology-Head and Neck Surgery and COVID-19.
    JAMA. 2020;324:1145-1146.

  135. WINKELMAYER WC, Khairallah P, Charytan DM
    Nephrology and COVID-19.
    JAMA. 2020;324:1137-1138.

  136. DISIS ML
    Oncology and COVID-19.
    JAMA. 2020;324:1141-1142.

    Ophthalmology and COVID-19.
    JAMA. 2020;324:1143-1144.

    JAMA Health Forum and COVID-19.
    JAMA. 2020;324:1155-1156.

  139. Influenza Vaccine for 2020-2021.
    JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.

    Pediatrics and COVID-19.
    JAMA. 2020;324:1147-1148.

  141. ONGUR D, Perlis R, Goff D
    Psychiatry and COVID-19.
    JAMA. 2020;324:1149-1150.

  142. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA. 2020 Aug 5. pii: 2769289. doi: 10.1001/jama.2020.15067.

  143. MELLO MM, Greene JA, Sharfstein JM
    Attacks on Public Health Officials During COVID-19.
    JAMA. 2020 Aug 5. pii: 2769291. doi: 10.1001/jama.2020.14423.

  144. PRESCOTT HC, Girard TD
    Recovery From Severe COVID-19: Leveraging the Lessons of Survival From Sepsis.
    JAMA. 2020 Aug 5. pii: 2769290. doi: 10.1001/jama.2020.14103.

  145. MOSCOLA J, Sembajwe G, Jarrett M, Farber B, et al
    Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.
    JAMA. 2020 Aug 6. pii: 2769322. doi: 10.1001/jama.2020.14765.

    Researchers Strive to Recruit Hard-Hit Minorities Into COVID-19 Vaccine Trials.
    JAMA. 2020 Aug 13. pii: 2769611. doi: 10.1001/jama.2020.11244.

  147. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response.
    JAMA. 2020 Aug 10. pii: 2769439. doi: 10.1001/jama.2020.14033.

  148. WANG EA, Zenilman J, Brinkley-Rubinstein L
    Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
    JAMA. 2020 Aug 17. pii: 2769694. doi: 10.1001/jama.2020.15589.

  149. SPINNER CD, Gottlieb RL, Criner GJ, Arribas Lopez JR, et al
    Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Aug 21. pii: 2769871. doi: 10.1001/jama.2020.16349.
    PubMed         Abstract available

  150. SLOMSKI A
    Telehealth Success Spurs a Call for Greater Post-COVID-19 License Portability.
    JAMA. 2020;324:1021-1022.

  151. BERKWITS M, Flanagin A, Bauchner H, Fontanarosa PB, et al
    The COVID-19 Pandemic and the JAMA Network.
    JAMA. 2020;324:1159-1160.

  152. JOSEPHSON SA, Kamel H
    Neurology and COVID-19.
    JAMA. 2020;324:1139-1140.


  153. HAGAY Z
    Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic.
    Lancet. 2020;396:882.

  154. LASRY A, Horth R
    Models for mortality require tailoring in the context of the COVID-19 pandemic.
    Lancet. 2020;396:883.

  155. BANERJEE A, Pasea L, Denaxas S, Williams B, et al
    Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:883-884.

  156. AGREN D
    Understanding Mexican health worker COVID-19 deaths.
    Lancet. 2020;396:807.

  157. BAR-ZEEV N, Inglesby T
    COVID-19 vaccines: early success and remaining challenges.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31867.

    Lancet Child Adolesc Health

  158. WEBB K, Abraham DR, Faleye A, McCulloch M, et al
    Multisystem inflammatory syndrome in children in South Africa.
    Lancet Child Adolesc Health. 2020;4:e38.

  159. SALVATORE CM, Han JY, Acker KP, Tiwari P, et al
    Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study.
    Lancet Child Adolesc Health. 2020 Jul 23. pii: S2352-4642(20)30235.
    PubMed         Abstract available

  160. SADIQ M, Aziz OA, Kazmi U, Hyder N, et al
    Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan.
    Lancet Child Adolesc Health. 2020 Aug 10. pii: S2352-4642(20)30256.

  161. DOLHNIKOFF M, Ferreira Ferranti J, de Almeida Monteiro RA, Duarte-Neto AN, et al
    SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome.
    Lancet Child Adolesc Health. 2020 Aug 20. pii: S2352-4642(20)30257.

    The abandoned children of the Islamic State.
    Lancet Child Adolesc Health. 2020;4:709.

    Lancet Diabetes Endocrinol

  163. HOLMAN N, Knighton P, Kar P, O'Keefe J, et al
    Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.
    Lancet Diabetes Endocrinol. 2020 Aug 13. pii: S2213-8587(20)30271.
    PubMed         Abstract available

  164. BARRON E, Bakhai C, Kar P, Weaver A, et al
    Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.
    Lancet Diabetes Endocrinol. 2020 Aug 13. pii: S2213-8587(20)30272.
    PubMed         Abstract available

    Lancet Gastroenterol Hepatol

    Axing of Public Health England: disease prevention in limbo.
    Lancet Gastroenterol Hepatol. 2020;5:875.

    Clinical research: further COVID-19 collateral damage.
    Lancet Gastroenterol Hepatol. 2020;5:875.

  167. BRENNER EJ, Ungaro RC, Colombel JF, Kappelman MD, et al
    IBD in the COVID-19 era: the value of international collaboration.
    Lancet Gastroenterol Hepatol. 2020;5:887-888.

    Lancet Glob Health

  168. MCCLURE EM, Kinney MV, Leisher SH, Nam SL, et al
    Impact of COVID-19 on maternal and child health.
    Lancet Glob Health. 2020 Aug 3. pii: S2214-109X(20)30326.

  169. CHOU VB, Carter ED, Sawadogo-Lewis T
    Impact of COVID-19 on maternal and child health - Authors' reply.
    Lancet Glob Health. 2020 Aug 3. pii: S2214-109X(20)30322.

  170. KARKEE R, Morgan A
    Providing maternal health services during the COVID-19 pandemic in Nepal.
    Lancet Glob Health. 2020 Aug 10. pii: S2214-109X(20)30350.

  171. DMELLO BS, Housseine N, van den Akker T, van Roosmalen J, et al
    Impact of COVID-19 on maternal and child health.
    Lancet Glob Health. 2020 Aug 3. pii: S2214-109X(20)30328.

  172. BUSCH-HALLEN J, Walters D, Rowe S, Chowdhury A, et al
    Impact of COVID-19 on maternal and child health.
    Lancet Glob Health. 2020 Aug 3. pii: S2214-109X(20)30327.

  173. MAINA M, Tosas-Auguet O, English M, Schultsz C, et al
    COVID-19: an opportunity to improve infection prevention and control in LMICs.
    Lancet Glob Health. 2020 Aug 13. pii: S2214-109X(20)30352.

  174. ABBAS K, Procter SR, van Zandvoort K, Clark A, et al
    Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
    Lancet Glob Health. 2020 Jul 17. pii: S2214-109X(20)30308.
    PubMed         Abstract available

  175. RAHMAN MM, Bodrud-Doza M, Griffiths MD, Mamun MA, et al
    Biomedical waste amid COVID-19: perspectives from Bangladesh.
    Lancet Glob Health. 2020 Aug 13. pii: S2214-109X(20)30349.

  176. PARK JJH, Decloedt EH, Rayner CR, Cotton M, et al
    Clinical trials of disease stages in COVID 19: complicated and often misinterpreted.
    Lancet Glob Health. 2020 Aug 20. pii: S2214-109X(20)30365.

  177. VERWEY C, Nunes MC
    RSV lower respiratory tract infection and lung health in the first 2 years of life.
    Lancet Glob Health. 2020;8:e1247-e1248.

  178. KC A, Gurung R, Kinney MV, Sunny AK, et al
    Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study.
    Lancet Glob Health. 2020 Aug 10. pii: S2214-109X(20)30345.
    PubMed         Abstract available

    Lancet Haematol

  179. PEREYRA D, Heber S, Jilma B, Zoufaly A, et al
    Routine haematological parameters in COVID-19 prognosis.
    Lancet Haematol. 2020;7:e709.

  180. RUBINSTEIN SM, Warner JL
    COVID-19 and haematological malignancy: navigating a narrow strait.
    Lancet Haematol. 2020 Aug 13. pii: S2352-3026(20)30252.

  181. PASSAMONTI F, Cattaneo C, Arcaini L, Bruna R, et al
    Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
    Lancet Haematol. 2020 Aug 13. pii: S2352-3026(20)30251.
    PubMed         Abstract available

  182. STANWORTH SJ, New HV, Apelseth TO, Brunskill S, et al
    Effects of the COVID-19 pandemic on supply and use of blood for transfusion.
    Lancet Haematol. 2020 Jul 3. pii: S2352-3026(20)30186.
    PubMed         Abstract available

    Lancet Infect Dis

  183. TILANGI P, Desai D, Khan A, Soneja M, et al
    Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
    Lancet Infect Dis. 2020 May 22. pii: S1473-3099(20)30430.

  184. GABORIT BJ, Bergmann JF, Mussini C, Arribas JR, et al
    Plea for multitargeted interventions for severe COVID-19.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30312.

  185. WELLS CR, Fitzpatrick MC, Sah P, Shoukat A, et al
    Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30315.

  186. RATHI S, Ish P, Kalantri A, Kalantri S, et al
    Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Lancet Infect Dis. 2020;20:1118-1119.

  187. YI ES, Cecchini MJ, Bois MC
    Pathologists in pursuit of the COVID-19 culprit.
    Lancet Infect Dis. 2020 Jun 8. pii: S1473-3099(20)30449.

    Curing COVID-19.
    Lancet Infect Dis. 2020 Sep 10. pii: S1473-3099(20)30706.

  189. AFRA TP, T MR, Bishnoi A, Hafi NB, et al
    Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
    Lancet Infect Dis. 2020 Jun 16. pii: S1473-3099(20)30472.

  190. YELIN D, Wirtheim E, Vetter P, Kalil AC, et al
    Long-term consequences of COVID-19: research needs.
    Lancet Infect Dis. 2020 Sep 1. pii: S1473-3099(20)30701.

  191. PRINCIPI N, Esposito S
    Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Lancet Infect Dis. 2020;20:1118.

    Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30512.

  193. PITZER VE, Cohen T
    Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2.
    Lancet Infect Dis. 2020 Jun 17. pii: S1473-3099(20)30514.

  194. GLYNN JR
    Protecting workers aged 60-69 years from COVID-19.
    Lancet Infect Dis. 2020 Apr 16. pii: S1473-3099(20)30311.

  195. ZHANG W, Qian BY
    Making decisions to mitigate COVID-19 with limited knowledge.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30280.

    Lancet Neurol

  196. COHEN ME, Eichel R, Steiner-Birmanns B, Janah A, et al
    A case of probable Parkinson's disease after SARS-CoV-2 infection.
    Lancet Neurol. 2020;19:804-805.

  197. HELBOK R, Chou SH, Beghi E, Mainali S, et al
    NeuroCOVID: it's time to join forces globally.
    Lancet Neurol. 2020;19:805-806.

    Lancet Psychiatry

  198. PIRNIA B, Pirnia F, Pirnia K
    Honour killings and violence against women in Iran during the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e60.

  199. RAHMAN A, Naslund JA, Betancourt TS, Black CJ, et al
    The NIMH global mental health research community and COVID-19.
    Lancet Psychiatry. 2020 Aug 21. pii: S2215-0366(20)30347.

  200. VARATHARAJ A, Thomas N, Ellul MA, Davies NWS, et al
    Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.
    Lancet Psychiatry. 2020 Jun 25. pii: S2215-0366(20)30287.
    PubMed         Abstract available

  201. PIERCE M, Hope H, Ford T, Hatch S, et al
    Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population.
    Lancet Psychiatry. 2020 Jul 21. pii: S2215-0366(20)30308.
    PubMed         Abstract available

    Lancet Public Health

  202. MCCAULEY L, Hayes R
    Taking responsibility for front-line health-care workers.
    Lancet Public Health. 2020;5:e461-e462.

  203. IVERS LC, Weitzner DJ
    Can digital contact tracing make up for lost time?
    Lancet Public Health. 2020;5:e417-e418.

    Lancet Respir Med

  204. WILLIAMS TC, Kim S, Spiro DJ, Campbell H, et al
    Preparing for the future implementation of respiratory syncytial virus vaccines.
    Lancet Respir Med. 2020 Jan 21. pii: S2213-2600(19)30478.

    MMWR Morb Mortal Wkly Rep

  205. LASH RR, Donovan CV, Fleischauer AT, Moore ZS, et al
    COVID-19 Contact Tracing in Two Counties - North Carolina, June-July 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1360-1363.
    PubMed         Abstract available

  206. DELAHOY MJ, Whitaker M, O'Halloran A, Chai SJ, et al
    Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1347-1354.
    PubMed         Abstract available

  207. LEWIS NM, Friedrichs M, Wagstaff S, Sage K, et al
    Disparities in COVID-19 Incidence, Hospitalizations, and Testing, by Area-Level Deprivation - Utah, March 3-July 9, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1369-1373.
    PubMed         Abstract available

  208. PANAGIOTAKOPOULOS L, Myers TR, Gee J, Lipkind HS, et al
    SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1355-1359.
    PubMed         Abstract available

  209. HUGHES MM, Groenewold MR, Lessem SE, Xu K, et al
    Update: Characteristics of Health Care Personnel with COVID-19 - United States, February 12-July 16, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1364-1368.
    PubMed         Abstract available

  210. LEEB RT, Price S, Sliwa S, Kimball A, et al
    COVID-19 Trends Among School-Aged Children - United States, March 1-September 19, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1410-1415.
    PubMed         Abstract available

  211. WILSON E, Donovan CV, Campbell M, Chai T, et al
    Multiple COVID-19 Clusters on a University Campus - North Carolina, August 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1416-1418.
    PubMed         Abstract available

  212. BOEHMER TK, DeVies J, Caruso E, van Santen KL, et al
    Changing Age Distribution of the COVID-19 Pandemic - United States, May-August 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1404-1409.
    PubMed         Abstract available

  213. RAZZAGHI H, Kahn KE, Black CL, Lindley MC, et al
    Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1391-1397.
    PubMed         Abstract available

  214. DIRLIKOV E, Fechter-Leggett E, Thorne SL, Worrell CM, et al
    CDC Deployments to State, Tribal, Local, and Territorial Health Departments for COVID-19 Emergency Public Health Response - United States, January 21-July 25, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1398-1403.
    PubMed         Abstract available

    N Engl J Med

  215. EGEDE LE, Walker RJ
    Structural Racism, Social Risk Factors, and Covid-19 - A Dangerous Convergence for Black Americans.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2023616.

  216. BERKOWITZ SA, Cene CW, Chatterjee A
    Covid-19 and Health Equity - Time to Think Big.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2021209.

  217. STUDDERT DM, Hall MA, Mello MM
    Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic.
    N Engl J Med. 2020 Aug 5. doi: 10.1056/NEJMp2024274.

  218. WYLLIE AL, Fournier J, Casanovas-Massana A, Campbell M, et al
    Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
    N Engl J Med. 2020 Aug 28. doi: 10.1056/NEJMc2016359.

  219. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
    N Engl J Med. 2020;383:e92.

  220. CHRISTIE A, Neatherlin JC, Nichol ST, Beach M, et al
    Ebola Response Priorities in the Time of Covid-19.
    N Engl J Med. 2020;383:1202-1204.

  221. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Eight Months of Action and Inaction against Covid-19.
    N Engl J Med. 2020;383:e95.


  222. SOKOL RL, Grummon AH
    COVID-19 and Parent Intention to Vaccinate Their Children Against Influenza.
    Pediatrics. 2020 Sep 30. pii: peds.2020-022871. doi: 10.1542/peds.2020-022871.

    PLoS Biol

  223. SELZER L, Su Z, Pintilie GD, Chiu W, et al
    Full-length three-dimensional structure of the influenza A virus M1 protein and its organization into a matrix layer.
    PLoS Biol. 2020;18:e3000827.
    PubMed         Abstract available

    PLoS Med

  224. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
    Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    PLoS Med. 2020;17:e1003293.
    PubMed         Abstract available

  225. RENTSCH CT, Kidwai-Khan F, Tate JP, Park LS, et al
    Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
    PLoS Med. 2020;17:e1003379.
    PubMed         Abstract available

  226. BUITRAGO-GARCIA D, Egli-Gany D, Counotte MJ, Hossmann S, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003346.
    PubMed         Abstract available

    PLoS One

  227. SOUBEYRAND S, Ribaud M, Baudrot V, Allard D, et al
    COVID-19 mortality dynamics: The future modelled as a (mixture of) past(s).
    PLoS One. 2020;15:e0238410.
    PubMed         Abstract available

  228. MITRA A, Pakhare AP, Roy A, Joshi A, et al
    Impact of COVID-19 epidemic curtailment strategies in selected Indian states: An analysis by reproduction number and doubling time with incidence modelling.
    PLoS One. 2020;15:e0239026.
    PubMed         Abstract available

  229. CHORUS C, Sandorf ED, Mouter N
    Diabolical dilemmas of COVID-19: An empirical study into Dutch society's trade-offs between health impacts and other effects of the lockdown.
    PLoS One. 2020;15:e0238683.
    PubMed         Abstract available

  230. PAVEL STI, Yetiskin H, Aydin G, Holyavkin C, et al
    Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
    PLoS One. 2020;15:e0238614.
    PubMed         Abstract available

  231. SRIVASTAVA A, Pandey RK, Singh PP, Kumar P, et al
    Most frequent South Asian haplotypes of ACE2 share identity by descent with East Eurasian populations.
    PLoS One. 2020;15:e0238255.
    PubMed         Abstract available

  232. PRAZUCK T, Colin M, Giache S, Gubavu C, et al
    Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    PLoS One. 2020;15:e0237694.
    PubMed         Abstract available

  233. MAROIS G, Muttarak R, Scherbov S
    Assessing the potential impact of COVID-19 on life expectancy.
    PLoS One. 2020;15:e0238678.
    PubMed         Abstract available

  234. TABERNERO C, Castillo-Mayen R, Luque B, Cuadrado E, et al
    Social values, self- and collective efficacy explaining behaviours in coping with Covid-19: Self-interested consumption and physical distancing in the first 10 days of confinement in Spain.
    PLoS One. 2020;15:e0238682.
    PubMed         Abstract available

  235. PACHECO-BARRIOS K, Cardenas-Rojas A, Giannoni-Luza S, Fregni F, et al
    COVID-19 pandemic and Farr's law: A global comparison and prediction of outbreak acceleration and deceleration rates.
    PLoS One. 2020;15:e0239175.
    PubMed         Abstract available

  236. KAUFMAN HW, Niles JK, Kroll MH, Bi C, et al
    SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.
    PLoS One. 2020;15:e0239252.
    PubMed         Abstract available

  237. SUTTON J, Renshaw SL, Butts CT
    COVID-19: Retransmission of official communications in an emerging pandemic.
    PLoS One. 2020;15:e0238491.
    PubMed         Abstract available

  238. MUSCILLO A, Pin P, Razzolini T
    Covid19: Unless one gets everyone to act, policies may be ineffective or even backfire.
    PLoS One. 2020;15:e0237057.
    PubMed         Abstract available

  239. HOSSAIN MT, Ahammed B, Chanda SK, Jahan N, et al
    Social and electronic media exposure and generalized anxiety disorder among people during COVID-19 outbreak in Bangladesh: A preliminary observation.
    PLoS One. 2020;15:e0238974.
    PubMed         Abstract available

  240. CAMPIGLIO L, Priori A
    Neurological symptoms in acute COVID-19 infected patients: A survey among Italian physicians.
    PLoS One. 2020;15:e0238159.
    PubMed         Abstract available

  241. GRAFFIGNA G, Barello S, Savarese M, Palamenghi L, et al
    Measuring Italian citizens' engagement in the first wave of the COVID-19 pandemic containment measures: A cross-sectional study.
    PLoS One. 2020;15:e0238613.
    PubMed         Abstract available

  242. CARRILLO-VEGA MF, Salinas-Escudero G, Garcia-Pena C, Gutierrez-Robledo LM, et al
    Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico.
    PLoS One. 2020;15:e0238905.
    PubMed         Abstract available

  243. HERRERO C, Villar A
    A synthetic indicator on the impact of COVID-19 on the community's health.
    PLoS One. 2020;15:e0238970.
    PubMed         Abstract available

  244. ZENG M, Li L, Wu Z
    Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.
    PLoS One. 2020;15:e0238828.
    PubMed         Abstract available

  245. MASTERS NB, Shih SF, Bukoff A, Akel KB, et al
    Social distancing in response to the novel coronavirus (COVID-19) in the United States.
    PLoS One. 2020;15:e0239025.
    PubMed         Abstract available

  246. BONFUL HA, Addo-Lartey A, Aheto JMK, Ganle JK, et al
    Limiting spread of COVID-19 in Ghana: Compliance audit of selected transportation stations in the Greater Accra region of Ghana.
    PLoS One. 2020;15:e0238971.
    PubMed         Abstract available

  247. DEBNATH R, Bardhan R
    India nudges to contain COVID-19 pandemic: A reactive public policy analysis using machine-learning based topic modelling.
    PLoS One. 2020;15:e0238972.
    PubMed         Abstract available

  248. WNUK A, Oleksy T, Maison D
    The acceptance of Covid-19 tracking technologies: The role of perceived threat, lack of control, and ideological beliefs.
    PLoS One. 2020;15:e0238973.
    PubMed         Abstract available

  249. BORGES DO NASCIMENTO IJ, von Groote TC, O'Mathuna DP, Abdulazeem HM, et al
    Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
    PLoS One. 2020;15:e0239235.
    PubMed         Abstract available

  250. COELHO FC, Lana RM, Cruz OG, Villela DAM, et al
    Assessing the spread of COVID-19 in Brazil: Mobility, morbidity and social vulnerability.
    PLoS One. 2020;15:e0238214.
    PubMed         Abstract available

  251. MECENAS P, Bastos RTDRM, Vallinoto ACR, Normando D, et al
    Effects of temperature and humidity on the spread of COVID-19: A systematic review.
    PLoS One. 2020;15:e0238339.
    PubMed         Abstract available

  252. PIEH C, O Rourke T, Budimir S, Probst T, et al
    Relationship quality and mental health during COVID-19 lockdown.
    PLoS One. 2020;15:e0238906.
    PubMed         Abstract available

  253. SUNTRONWONG N, Vichaiwattana P, Klinfueng S, Korkong S, et al
    Climate factors influence seasonal influenza activity in Bangkok, Thailand.
    PLoS One. 2020;15:e0239729.
    PubMed         Abstract available

  254. SZETO WC, Hsia HP, Tang YS, Shaw PC, et al
    Interaction between influenza A virus nucleoprotein and PB2 cap-binding domain is mediated by RNA.
    PLoS One. 2020;15:e0239899.
    PubMed         Abstract available

  255. GOLINELLI D, Boetto E, Maietti E, Fantini MP, et al
    The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis.
    PLoS One. 2020;15:e0239508.
    PubMed         Abstract available

  256. PARLIN AF, Stratton SM, Culley TM, Guerra PA, et al
    A laboratory-based study examining the properties of silk fabric to evaluate its potential as a protective barrier for personal protective equipment and as a functional material for face coverings during the COVID-19 pandemic.
    PLoS One. 2020;15:e0239531.
    PubMed         Abstract available

  257. JILLELLA DV, Janocko NJ, Nahab F, Benameur K, et al
    Ischemic stroke in COVID-19: An urgent need for early identification and management.
    PLoS One. 2020;15:e0239443.
    PubMed         Abstract available

  258. GORDON JL, Balsom AA
    The psychological impact of fertility treatment suspensions during the COVID-19 pandemic.
    PLoS One. 2020;15:e0239253.
    PubMed         Abstract available

  259. KRAUSE M, Douin DJ, Tran TT, Fernandez-Bustamante A, et al
    Association between procalcitonin levels and duration of mechanical ventilation in COVID-19 patients.
    PLoS One. 2020;15:e0239174.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  260. THURNER S, Klimek P, Hanel R
    A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2020;117:22684-22689.
    PubMed         Abstract available

  261. GANGULI A, Mostafa A, Berger J, Aydin MY, et al
    Rapid isothermal amplification and portable detection system for SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020;117:22727-22735.
    PubMed         Abstract available

  262. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
    A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
    PubMed         Abstract available


  263. GALILI U
    Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes.
    Vaccine. 2020 Aug 19. pii: S0264-410X(20)31073.
    PubMed         Abstract available

  264. GRADY C, Shah S, Miller F, Danis M, et al
    So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.
    Vaccine. 2020 Aug 11. pii: S0264-410X(20)31048.
    PubMed         Abstract available

  265. YITBAREK K, Abraham G, Girma T, Tilahun T, et al
    The effect of Bacillus Calmette-Guerin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Vaccine. 2020 Aug 10. pii: S0264-410X(20)31049.
    PubMed         Abstract available

    Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31339.
    PubMed         Abstract available

  267. GILES ML, Buttery J, Davey MA, Wallace E, et al
    Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Vaccine. 2019 Sep 17. pii: S0264-410X(19)31173.
    PubMed         Abstract available

  268. PATEL N, Massare MJ, Tian JH, Guebre-Xabier M, et al
    Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
    Vaccine. 2019 Aug 12. pii: S0264-410X(19)31010.
    PubMed         Abstract available

  269. TORCEL-PAGNON L, Bauchau V, Mahy P, Tin Tin Htar M, et al
    Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30561.
    PubMed         Abstract available

  270. TEMPIA S, Moyes J, Cohen AL, Walaza S, et al
    Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015.
    Vaccine. 2020 Sep 23. pii: S0264-410X(20)31193.
    PubMed         Abstract available

  271. WANG K, Wong ELY, Ho KF, Cheung AWL, et al
    Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey.
    Vaccine. 2020 Sep 10. pii: S0264-410X(20)31175.
    PubMed         Abstract available

  272. REITER PL, Pennell ML, Katz ML
    Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31084.
    PubMed         Abstract available

  273. TOMITA Y, Sato R, Ikeda T, Sakagami T, et al
    BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31086.
    PubMed         Abstract available


  274. NISSLY RH, Zaman N, Ibrahim PAS, McDaniel K, et al
    Influenza C and D viral load in cattle correlates with bovine respiratory disease (BRD): Emerging role of orthomyxoviruses in the pathogenesis of BRD.
    Virology. 2020;551:10-15.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.